CTI BioPharma Statistics
Total Valuation
HKG:1080 has a market cap or net worth of HKD 275.08 million. The enterprise value is 479.72 million.
Market Cap | 275.08M |
Enterprise Value | 479.72M |
Important Dates
The next estimated earnings date is Tuesday, August 26, 2025.
Earnings Date | Aug 26, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
HKG:1080 has 3.87 billion shares outstanding.
Current Share Class | 3.87B |
Shares Outstanding | 3.87B |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 7.39% |
Owned by Institutions (%) | n/a |
Float | 2.37B |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.45 |
PB Ratio | 0.60 |
P/TBV Ratio | 0.62 |
P/FCF Ratio | 19.72 |
P/OCF Ratio | 15.92 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -10.59 |
EV / Sales | 0.79 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 34.39 |
Financial Position
The company has a current ratio of 0.97, with a Debt / Equity ratio of 0.73.
Current Ratio | 0.97 |
Quick Ratio | 0.42 |
Debt / Equity | 0.73 |
Debt / EBITDA | n/a |
Debt / FCF | 23.72 |
Interest Coverage | -3.67 |
Financial Efficiency
Return on equity (ROE) is -9.31% and return on invested capital (ROIC) is -4.04%.
Return on Equity (ROE) | -9.31% |
Return on Assets (ROA) | -2.96% |
Return on Invested Capital (ROIC) | -4.04% |
Return on Capital Employed (ROCE) | -9.52% |
Revenue Per Employee | 1.32M |
Profits Per Employee | -98,255 |
Employee Count | 461 |
Asset Turnover | 0.53 |
Inventory Turnover | 4.08 |
Taxes
In the past 12 months, HKG:1080 has paid 60,658 in taxes.
Income Tax | 60,658 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +153.57% in the last 52 weeks. The beta is -0.97, so HKG:1080's price volatility has been lower than the market average.
Beta (5Y) | -0.97 |
52-Week Price Change | +153.57% |
50-Day Moving Average | 0.04 |
200-Day Moving Average | 0.04 |
Relative Strength Index (RSI) | 73.64 |
Average Volume (20 Days) | 9,146,450 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1080 had revenue of HKD 606.65 million and -45.30 million in losses. Loss per share was -0.01.
Revenue | 606.65M |
Gross Profit | 62.93M |
Operating Income | -54.13M |
Pretax Income | -46.07M |
Net Income | -45.30M |
EBITDA | -33.50M |
EBIT | -54.13M |
Loss Per Share | -0.01 |
Balance Sheet
The company has 135.92 million in cash and 330.83 million in debt, giving a net cash position of -194.91 million or -0.05 per share.
Cash & Cash Equivalents | 135.92M |
Total Debt | 330.83M |
Net Cash | -194.91M |
Net Cash Per Share | -0.05 |
Equity (Book Value) | 454.75M |
Book Value Per Share | 0.11 |
Working Capital | -16.34M |
Cash Flow
In the last 12 months, operating cash flow was 17.28 million and capital expenditures -3.34 million, giving a free cash flow of 13.95 million.
Operating Cash Flow | 17.28M |
Capital Expenditures | -3.34M |
Free Cash Flow | 13.95M |
FCF Per Share | 0.00 |
Margins
Gross margin is 10.37%, with operating and profit margins of -8.92% and -7.47%.
Gross Margin | 10.37% |
Operating Margin | -8.92% |
Pretax Margin | -7.59% |
Profit Margin | -7.47% |
EBITDA Margin | -5.52% |
EBIT Margin | -8.92% |
FCF Margin | 2.30% |
Dividends & Yields
HKG:1080 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -16.47% |
FCF Yield | 5.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
HKG:1080 has an Altman Z-Score of -0.98 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.98 |
Piotroski F-Score | 4 |